Telecom giant Verizon Communications (NYSE: VZ) reported a decline in second-quarter revenues, reflecting the disruption caused by the pandemic. Consequently, earnings decreased 4% annually but came in above the market’s forecast.
Operating revenues dropped 5.1% annually to $30.4 billion, which was slightly above the consensus estimate. Adjusted earnings declined to $1.18 per share from $1.23 per share in the second quarter of 2020. Unadjusted profit was $1.13 per share, up from $0.95 per share recorded a year earlier.
Verizon’s stock made modest gains early Friday following the announcement. It had closed the last trading session slightly higher.
After registering a slow recovery in the first half of the week, the markets pared these gains on Thursday and Friday. The weakness witnessed in the latter half of the
Illumina, Inc. (NASDAQ: ILMN), a pioneer in genome sequencing technology, has strived to strengthen its unique position in the healthcare sector through strategic partnerships and technological innovation. Its performance so
The COVID-19 pandemic raged through the first half of this year and continues to impact the world without signs of abating. Amid this health crisis, several companies reported strong results